-->

Gene Therapy Company Gets a Boost

Post a Comment
Trade of the Day Wake-Up Watchlist

Good morning Wake-Up Watchlisters! While you're sipping coffee you'll see stock futures fell on Monday after all three major indexes turned in their worst week in three months. Investors are preparing for the Federal Reserve's two-day policy meeting on Sept. 20-21. The central bank will likely deliver a third-straight 75-basis-point increase.

When markets are falling, it's vital you know how to make money regardless of a stock's direction. That's why we're focusing on 'The Perfect Timing Pattern' in The War Room. This is a simple pattern you can learn in just one day that's helping investors weather the 2022 Wall Street storm.

Click here to learn about 'The Perfect Timing Pattern.'

 

Here's a look at the top-moving stocks this morning.

Bluebird Bio (Nasdaq: BLUE)

Bluebird Bio is up 14.51% premarket after the biotech company netted a second key win from the U.S. Food and Drug Administration. The FDA approved bluebird's gene tehrapy eli-cel, which is designed to treat boys ages 4-17 with the neurological disorder cerebral adrenoleukodystrophy. The drug has a wholesale cost of $3 million, according to the company.

Medical technology has come a long way, and there are so many buying opportunities to be had in this sector. Our friend Alexander Green is high on one particular company. He's calling this technology "the most incredible investment opportunity in 37 years."

Click here to unlock this $3 stock.

 

VEON (Nasdaq: VEON)

VEON is up 11.08% premarket after the company continues its operational momentum. Service revenue increased 4.3%, with five of seven countries reporting double-digit local currency revenue growth for the period. VEON is a telecommunications company that operates predominantly in Asia, Africa and Europe.

 

The New King of Electric Vehicles

Electric Car Stats
 

You probably haven't heard about this revolutionary car. Or the little-known company behind it.

Yet it could soon become the new king of the EV industry.

>> See the details HERE <<

Cingulate (Nasdaq: CING)

Cingulate is up 13.95% premarket after the latest findings for its three time-release oral tablets to help with anxiety. These tablets are designed to deliver a triple release of buspirone hydrochloride, and based on the dissolution profile seen in the data, the Ctx-2103 30mg tablet achieved the solubility required to do that.

 

Wix.com (Nasdaq: WIX)

Wix is up 6.53% premarket after activist investor Starboard Value revealed a 9% stake in the company, which was later confirmed. Starboard said the purpose of the transaction was because it considered shares to be "undervalued and represented an attractive investment opportunity."

Knowing when insiders are buying into a company can help you make massive gains in the market. That's exactly what our Head Fundamental Tactician Karim Rahemtulla does with his Insider Matrix.

Click here to see how tracking insider buying could turn every $5k into $117,500!.

 

Those are the top market movers today.

Happy trading!

The Wake-Up Watchlist Research Team

Office or Jet
 

At the top of every major office building...

Or on board every private jet...

Sits a CEO, who knows exactly when to buy their company's stock.

With Insider Matrix, you can track their buys - in real time - and know precisely when they bought and exactly what price they paid. It's time you learned how to trade like an insider.

Introducing...

Insider Matrix
 

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter